Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Phio Pharmaceuticals Corp. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 18 | 15 | −3 |
| Shares | 990.1K | 707.5K | −282.6K (−28.5%) |
| Value | $991.0K | $626.0K | −$365.0K (−36.8%) |
New holders (1)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 1,000 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Two Sigma Investments, LP | 128,724 | $129.0K |
| Citadel Advisors LLC | 29,097 | $29.0K |
| Susquehanna International Group, LLP | 17,419 | $17.0K |
| Bank of America Corp | 16 | $0 |